Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Blocking interferon-gamma might help treat various autoimmune diseases.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

People with alopecia have a higher risk of thyroid cancer.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Both mouse and rat models are effective for testing alopecia areata treatments.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Blocking LFA-1 prevents hair loss in mice.